Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Anpac Bio-Medical Science Co., Ltd
{{company.company_channel.channel_name}}
Media Room
Latest
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
Fresh2 Group Ltd. Announces Acquisition of Cross-Border Food E-Commerce Platform Youfood Group Inc.
2024-01-04 22:00
Appointment of New Independent Director
2023-12-16 05:01
Fresh2 Group Launches Roxe Restaurant Robots, Spearheading Smart Automation in Culinary Services
2023-12-12 22:15
Fresh2 Group Ltd. Completes Acquisition of SpeedIn INC, a Delivery Service Provider
2023-07-28 21:00
Fresh2 Group Ltd. Appoints New Chief Strategy Officer to Drive Advancement and Execution of Long-Term Growth Strategy
2023-07-26 21:00
Fresh2 Group Ltd. Regains Compliance with Nasdaq Listing Requirements
2023-06-12 21:00
Fresh2 Group Ltd. Announces US$4.4 Million Private Placement
2023-06-05 21:00
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES'
2023-05-20 00:55
Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022
2023-05-17 05:00
Fresh2 Reports Fiscal Year 2022 Annual Financial Results
2023-05-17 04:15
Fresh2 Reports First Quarter of Fiscal Year 2023 Financial Results
2023-05-17 04:15
AnPac Bio-Medical Science Announces Closing of $3.0 Million Registered Direct Offering
2023-04-07 07:15
AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc.
2023-04-03 21:00
AnPac Bio-Medical Science Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting the Equity Rule on or before July 12, 2023
2023-03-23 20:00
AnPac Bio Announces Receipt of the First Payment from a Malaysia Customer On a Signed US$1.5 Million Cancer Detection Equipment Purchase Contract
2023-03-07 20:30
AnPac Bio-Medical Science Announces US$5 Million Private Placement
2023-03-06 21:30
AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study
2023-02-22 20:30
AnPac Bio-Medical Science Acquires GISN (HK) LIMITED, a Technical Solution and Outsourcing Consulting Services Provider
2023-02-15 21:00
AnPac Bio-Medical Science Enters into Definitive Agreement to Make Another Acquisition to Significantly Expand Scope of Business in the U.S.
2023-02-13 21:00
1